JP2014520786A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014520786A5 JP2014520786A5 JP2014517820A JP2014517820A JP2014520786A5 JP 2014520786 A5 JP2014520786 A5 JP 2014520786A5 JP 2014517820 A JP2014517820 A JP 2014517820A JP 2014517820 A JP2014517820 A JP 2014517820A JP 2014520786 A5 JP2014520786 A5 JP 2014520786A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11173066.9 | 2011-07-07 | ||
| EP11173066 | 2011-07-07 | ||
| PCT/EP2012/063242 WO2013004816A1 (en) | 2011-07-07 | 2012-07-06 | Darunavir formulations |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014520786A JP2014520786A (ja) | 2014-08-25 |
| JP2014520786A5 true JP2014520786A5 (https=) | 2015-07-16 |
| JP6101260B2 JP6101260B2 (ja) | 2017-03-22 |
Family
ID=46458539
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014517820A Active JP6101260B2 (ja) | 2011-07-07 | 2012-07-06 | ダルナビル製剤 |
Country Status (23)
| Country | Link |
|---|---|
| US (3) | US20140142174A1 (https=) |
| EP (1) | EP2729128B1 (https=) |
| JP (1) | JP6101260B2 (https=) |
| KR (1) | KR101817991B1 (https=) |
| CN (1) | CN103841962B (https=) |
| AU (1) | AU2012280277B2 (https=) |
| BR (1) | BR112014000195A2 (https=) |
| CA (1) | CA2837539C (https=) |
| CY (1) | CY1119446T1 (https=) |
| DK (1) | DK2729128T3 (https=) |
| EA (1) | EA026588B1 (https=) |
| ES (1) | ES2598823T3 (https=) |
| HR (1) | HRP20161340T1 (https=) |
| HU (1) | HUE030341T2 (https=) |
| IL (1) | IL229700B (https=) |
| LT (1) | LT2729128T (https=) |
| MX (1) | MX341976B (https=) |
| PL (1) | PL2729128T3 (https=) |
| PT (1) | PT2729128T (https=) |
| RS (1) | RS55236B1 (https=) |
| SI (1) | SI2729128T1 (https=) |
| SM (1) | SMT201600380B (https=) |
| WO (1) | WO2013004816A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2729130B1 (en) | 2011-07-07 | 2017-09-06 | Janssen Sciences Ireland UC | Darunavir combination formulations |
| HK1220390A1 (zh) | 2013-08-29 | 2017-05-05 | Teva Pharmaceutical Industries Ltd. | 包括恩曲他滨，替诺福韦，达芦那韦和利托那韦的单位剂型以及包含达芦那韦和利托那韦的单体片剂 |
| JP5843986B2 (ja) * | 2014-03-25 | 2016-01-13 | アステラス製薬株式会社 | 粒状医薬組成物 |
| CA2942877A1 (en) | 2014-04-08 | 2015-10-15 | Nitzan SHAHAR | Unit dosage form comprising emtricitabine, tenofovir, darunavir and ritonavir |
| EP3210017B1 (en) | 2014-10-26 | 2021-10-06 | King Abdullah University Of Science And Technology | Alkaloids from sponge, scaffolds for the inhibition of human immunodeficiency virus (hiv) |
| EP3654951A1 (en) | 2017-07-20 | 2020-05-27 | Janssen Sciences Ireland Unlimited Company | Compositions comprising darunavir, cobicistat, emtricitabine and tenofovir alafenamide for use in the treatment of hiv |
| SI3836920T1 (sl) | 2018-08-17 | 2026-02-27 | Eidos Therapeutics, Inc. | Formulacije AG10 |
| WO2020064980A1 (en) | 2018-09-28 | 2020-04-02 | Janssen Sciences Ireland Unlimited Company | Methods of treating and preventing neuropsychiatric and/or neurocognitive complications in patients infected with hiv |
| US20210290590A1 (en) | 2020-03-13 | 2021-09-23 | Janssen Sciences Ireland Unlimited Company | Methods of treating subjects infected with hiv |
| CA3172889C (en) * | 2020-04-20 | 2024-05-28 | John Docherty | Compositions and methods for enhanced delivery of antiviral agents |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5968942A (en) | 1992-08-25 | 1999-10-19 | G. D. Searle & Co. | α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| EP0715618B1 (en) | 1993-08-24 | 1998-12-16 | G.D. Searle & Co. | Hydroxyethylamino sulphonamides useful as retroviral protease inhibitors |
| CA2872424C (en) | 1998-06-23 | 2017-03-07 | The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Bisfuran derivatives useful in preventing the emergence of multidrug resistant hiv strains and treatment of hiv |
| TWI286476B (en) | 2001-12-12 | 2007-09-11 | Tibotec Pharm Ltd | Combination of cytochrome P450 dependent protease inhibitors |
| JP2010531301A (ja) * | 2007-06-25 | 2010-09-24 | テイボテク・フアーマシユーチカルズ | ダルナビル及びエトラビリンを含んでなる組み合わせ調剤 |
| AR069539A1 (es) * | 2007-07-25 | 2010-02-03 | Tibotec Pharm Ltd | Avances respecto de las formulaciones de comprimidos contra el vih |
| GT200800303A (es) * | 2007-12-24 | 2009-09-18 | Combinacion anti-retroviral | |
| CA2776807C (en) * | 2009-09-17 | 2018-10-16 | Mylan Laboratories Limited | An improved process for the preparation of darunavir |
-
2012
- 2012-07-06 SI SI201230742A patent/SI2729128T1/sl unknown
- 2012-07-06 RS RS20160872A patent/RS55236B1/sr unknown
- 2012-07-06 HR HRP20161340TT patent/HRP20161340T1/hr unknown
- 2012-07-06 EA EA201490223A patent/EA026588B1/ru unknown
- 2012-07-06 US US14/131,272 patent/US20140142174A1/en not_active Abandoned
- 2012-07-06 AU AU2012280277A patent/AU2012280277B2/en active Active
- 2012-07-06 JP JP2014517820A patent/JP6101260B2/ja active Active
- 2012-07-06 PL PL12732668T patent/PL2729128T3/pl unknown
- 2012-07-06 HU HUE12732668A patent/HUE030341T2/en unknown
- 2012-07-06 LT LTEP12732668.4T patent/LT2729128T/lt unknown
- 2012-07-06 WO PCT/EP2012/063242 patent/WO2013004816A1/en not_active Ceased
- 2012-07-06 ES ES12732668.4T patent/ES2598823T3/es active Active
- 2012-07-06 EP EP12732668.4A patent/EP2729128B1/en active Active
- 2012-07-06 KR KR1020147000084A patent/KR101817991B1/ko active Active
- 2012-07-06 MX MX2013015196A patent/MX341976B/es active IP Right Grant
- 2012-07-06 CA CA2837539A patent/CA2837539C/en active Active
- 2012-07-06 PT PT127326684T patent/PT2729128T/pt unknown
- 2012-07-06 BR BR112014000195A patent/BR112014000195A2/pt not_active Application Discontinuation
- 2012-07-06 CN CN201280033515.0A patent/CN103841962B/zh active Active
- 2012-07-06 DK DK12732668.4T patent/DK2729128T3/en active
-
2013
- 2013-11-28 IL IL229700A patent/IL229700B/en active IP Right Grant
-
2016
- 2016-01-07 US US14/990,621 patent/US20160113949A1/en not_active Abandoned
- 2016-10-25 CY CY20161101073T patent/CY1119446T1/el unknown
- 2016-10-26 SM SM201600380T patent/SMT201600380B/it unknown
-
2021
- 2021-04-27 US US17/242,218 patent/US20210244749A1/en not_active Abandoned